A major challenge for the development of an effective vaccine against tuberculosis (TB) is that the attributes of protective CD4+ T cell responses are still elusive for human TB. Infection with human immunodeficiency virus-1 (HIV-1) is a major risk factor for tuberculosis (TB), and a better understanding of HIV-induced alterations of Mycobacterium tuberculosis (Mtb)-specific CD4+ T cells that leads to failed host resistance may provide insight into protective T cell immunity to TB.
Eighty-six participants from a TB-endemic setting, either HIV-infected or -uninfected and with latent or active TB, were screened using Mtb-specific MHC class II tetramers. We examined the phenotype as well as function of ex vivo Mtb-specific tetramer+CD4+ T cells using flow cytometry.
The numbers of Mtb-specific tetramer+CD4+ T cells were relatively well maintained in HIV-infected persons with active TB, despite severe immunodeficiency. However, while HIV-uninfected persons with latent TB infection exhibited ex vivo Mtb-specific CD4+ T cells predominantly of a CXCR3+CCR6+CCR4- (Th1*) phenotype; active TB or HIV infection was associated with a contraction of this subset. Nevertheless, in individuals with active TB and/or HIV infection, circulating ex vivo Mtb-specific CD4+ T cells did not display defects in exhaustion or polyfunctionality compared to healthy HIV-uninfected individuals with latent TB infection.
Collectively, these data suggest that increased susceptibility to TB disease could be related to a loss of circulating Th1* CD4+ T cells rather than major changes in the number or function of circulating CD4+ T cells.